Q32 Bio Inc.
QTTB
$3.66
$0.257.33%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 22.13% | 13.98% | 22.26% | 19.36% | -3.63% |
| Total Depreciation and Amortization | 0.00% | -23.53% | -0.83% | -2.44% | 1.65% |
| Total Amortization of Deferred Charges | -6.12% | 2.08% | -2.04% | -2.00% | -24.24% |
| Total Other Non-Cash Items | -33.60% | 230.97% | -62.48% | 37.23% | -11.55% |
| Change in Net Operating Assets | 150.98% | -48.81% | -328.44% | 129.70% | 51.47% |
| Cash from Operations | 60.29% | 14.67% | -9.22% | 41.46% | 12.12% |
| Capital Expenditure | -- | -- | -- | 96.55% | -286.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | 0.98% |
| Cash from Investing | -- | -- | -- | -100.02% | 0.55% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -68.20% | 162.37% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -68.20% | 118.06% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 45.61% | 14.67% | -12.32% | -29.48% | 51.91% |